ESMO 2022: PRESTO - a phase III androgen annihilation in biochemically relapsed prostate cancer

Rahul Aggarwal describes the results of this randomised phase III study. 

2356 232

Suggested Podcasts

J.T. O'Donnell

Zero Waste Life Hacks Podcast

Kathrin Zenkina

Ammon a Taylor

Muslim Central

thegreenroom404

Night Vale Presents